He said Pfizer's pursuit of Astrazeneca has stirred up a wealth of protectionism, even if it's a global company Editor's note: Roger Barker is Director of Corporate Governance and Professional Standards at the Institute of Directors.
↧
He said Pfizer's pursuit of Astrazeneca has stirred up a wealth of protectionism, even if it's a global company Editor's note: Roger Barker is Director of Corporate Governance and Professional Standards at the Institute of Directors.